| Name | Title | Contact Details |
|---|---|---|
Carlos Rico |
Chief Financial Officer | Profile |
EKOS Corporation was founded in 1995 with the vision that ultrasound could accelerate the delivery of drugs to benefit patients with a variety of diseases and conditions. Today, EKOS is the world leader in providing ultrasound-assisted, fluid infusion
Our technology has been tested by top institutions and is used in hundreds of facilities throughout the world. We developed a technology that significantly reduces unhealthy contaminants. This technology quickly and effectively decreases airborne viruses, bacteria, particulates, mold, VOCs and odors. It cleans the air and creates a healthier environment.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
Organ Recovery Systems is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Red Rock Behavioral Health Services is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.